4893 items matching your search terms.

After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study

White, HD; Barbash, GI; Modan, M; Simes, J; Diaz, R; Hampton, JR; Heikkila, J; Kristinsson, A; Moulopoulos, S; Paolasso, EA; Van de Werf, H; Pehrsson, K; Sandoe, E; Wilcox, RG; Verstraete, M; Von der Lippe, G; for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality study,

After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study

White, H. D.; Barbash, G. I.; Modan, M.; Simes, J.; Van de Werf, F.

Global utilisation of streptokinase and tissue plasminogen activator for occluded arteries: the GUSTO study

White, H.; Simes, R.J.; Aylward, P.

Antecedent angina pectoris predicts worse outcome after acute myocardial infarction: experience gleaned from the International tissue plasminogen activator/streptokinase study

Barbash, GI; White. HD; Diaz, R; Hampton, JR; Heikkila, J; Kristinnson, A; Moulopoulos, S; Paolasso, E; Pehrsson, K; Sandoe, E; Simes, RJ; Wilcox, RG; Verstraate, M; von der Lippe, G; Van de Werf, F

The management of hyperlipidaemia: a consensus statement. Canberra, 16-18 October 1991.

Beilin, L; Heller, R; Butler, J; Simes, RJ; Calvert, D; Birkett, D; Sullivan, D; Mudge, P; Kniha, E; Thompson, P; Marley, JE

Use of chemotherapy, surgery and radiotherapy for squamous cell carcinoma of the head and neck

Beller, E.; Dalley, D.N.; Simes, R.J.

Breast conservation: long-term Australian data

Boyages, J. Bosch, C. Langlands, A. O. Bilous, A. M. Barraclough, B. Gebski, V. J.

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group

Coates, A. Gebski, V. Signorini, D. Murray, P. McNeil, D. Byrne, M. Forbes, J. F.

Patient Assessment of Adjuvant Treatment in Operable Breast Cancer

Coates, A.S.; Simes, R.J.

Cholesterol and total mortality: Need for larger trials [1]

Collins, R. Keech, A. Peto, R. Sleight, P. Kjekshus, J. Wilhelmsen, I. MacMahon, S. Shaw, J. Simes, J. Braunwald, E. Buring, J. Hennekens, C. Pfeffer, M. Sacks, F. Probstfield, J. Yusuf, S. Downs, J. R. Gotto, A. Cobbe, S.

Cholesterol and total mortality: need for larger trials [letter]

Collins, R Keech, A Peto, R; Sleight, P; Kjekshus, J; Wilhelmsen, L; MacMahon, S; Shaw, J; Simes, J; Braunwald, E; Buring, J Hennekens, C; Pfeffer, M; Sacks, F; Probstfield, J; Yusuf, S; Downs, JR; Gotto, A; Cobbe, S; Ford, I; Shepherd, F

Frequency of citation and outcome of cholesterol lowering trials [2]

Durrington, P. N. Laker, M. F. Keech, A. Goodwin, J. F. Game, F. L. Neary, R. H. Anderson, J. Burr, M. L. Fehily, A. M. Sweetnam, P. M. Elwood, P. C. Thompson, G. R. Ravnskov, U.

SPIDA User Manual

Gebski, V. Leung, O. McNeil, D. Lunn, D.

Quality of life in clinical trials of adjuvant therapies

Gelber, RD; Goldhirsch, A; Hurny, C; Simes, RJ; for the International Breast Cancer Study Group,

High versus low dose cisplatin in epithelial ovarian cancer

Ghersi, D. Parmar, M. K. Guthrie, D. Williams, C.